Catalent Appoints Kay Schmidt to Lead Technical Operations
SOMERSET, N.J. – February 21, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment of Kay Schmidt as Senior Vice President, Technical Operations. In this new role, Ms. Schmidt will lead a team dedicated to continuously improving the technical and operational excellence that enables Catalent to help its customers develop and launch over 200 new products every year.
Reporting to Alessandro Maselli, who earlier this month was appointed as Catalent’s new President and Chief Operating Officer, Ms. Schmidt and the Technical Operations organization will also focus on excellence and continuous improvement in our project management efforts, including new product launches, technical transfers, engineering projects, and customer engagements, as well as managing Catalent’s environmental, health, security, and safety processes.
“Kay’s experience in overseeing numerous large-scale programs makes her the ideal candidate to lead this vital function,” commented Mr. Maselli. He added, “In today’s pharmaceutical industry, coupling speed with continuous improvement, technical expertise, and operational consistency is critical to the ongoing success of our customer programs and enduring partnerships.”
Ms. Schmidt joined Catalent in 2009, holding several leadership roles in product development across multiple drug delivery dosage forms. Most recently, she provided leadership to Catalent’s global virtual Project Management Organization for new product introductions, in addition to her role as Vice President, Product Development in the company’s Biologics and Specialty Drug Delivery business unit. Prior to joining Catalent, she held various leadership roles at GE Healthcare developing and delivering diagnostic imaging technologies. She is a certified Six Sigma Green Belt, and has a bachelor’s degree from Carroll University, Wisconsin and a master’s degree from the University of Wisconsin-Whitewater.
+44 (0)7580 041073
+44 (0) 161 728 5880
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.